Cargando…

Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry

PURPOSE: A prior history of breast cancer is a risk factor for the subsequent development of primary peritoneal, epithelial ovarian, and fallopian tubal (POFT) cancers. This study aimed to estimate the incidence of secondary POFT malignancy in breast cancer patients and the clinical outcomes of prim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Hyeong In, Lee, Eun-Gyeong, Lim, Jiwon, Jung, So-Youn, Chang, Yoon Jung, Won, Young-Joo, Lim, Myong Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053875/ https://www.ncbi.nlm.nih.gov/pubmed/33211942 http://dx.doi.org/10.4143/crt.2020.1001

Ejemplares similares

Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study
por: Lee, Eun-Gyeong, et al.
Publicado: (2023)

Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study
por: Lim, Myong Cheol, et al.
Publicado: (2018)

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers
por: Ha, Hyeong In, et al.
Publicado: (2020)

Comparing the Characteristics and Outcomes of Male and Female Breast Cancer Patients in Korea: Korea Central Cancer Registry
por: Lee, Eun-Gyeong, et al.
Publicado: (2020)

Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999–2016: a retrospective study based on the Korean National Cancer Incidence Database
por: Shin, Wonkyo, et al.
Publicado: (2020)

Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
por: Lee, Maria, et al.
Publicado: (2019)

The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry
por: Ha, Hyeong In, et al.
Publicado: (2021)

Correction of Funding information: The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999–2017: Korea Central Cancer Registry
por: Ha, Hyeong In, et al.
Publicado: (2022)

Incidence and treatment outcomes of uterine cervical cancer in Korea 1999–2018 from the national cancer registry
por: Suh, Dong Hoon, et al.
Publicado: (2023)

Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study
por: Kim, Se Ik, et al.
Publicado: (2022)

Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review
por: Zagouri, Flora, et al.
Publicado: (2015)

Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers
por: Martin, Jovana Y., et al.
Publicado: (2016)

The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
por: Tokunaga, Hideki, et al.
Publicado: (2021)

A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers
por: Vasey, P A, et al.
Publicado: (2008)

Safety and Efficacy of Video Laparoscopic Surgical Debulking of Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
por: Nezhat, Farr R., et al.
Publicado: (2012)

Discussing maintenance therapy for ovarian, peritoneal, and fallopian tube cancers
por: Mercier, Ann Marie, et al.
Publicado: (2023)

Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer
por: Lim, Myong Cheol, et al.
Publicado: (2016)

Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO)
por: Choi, Min Chul, et al.
Publicado: (2016)

Primary Fallopian Tube Cancer in an 89-Year-Old Patient
por: Kontomanolis, Emmanuel N., et al.
Publicado: (2021)

Bilateral Primary Carcinoma of the Fallopian Tubes
por: Naidu, V. R., et al.
Publicado: (1944)

Primary hydatic cyst of the fallopian tube
por: Ben Ismail, Imen, et al.
Publicado: (2020)

Primary Treatment Results in Patients with Ovarian, Fallopian or Peritoneal Cancer—Results of a Clinical Cancer Registry Database Analysis in Germany
por: Armbrust, Robert, et al.
Publicado: (2022)

Asymptomatic Primary Fallopian Tube Cancer: An Unusual Cause of Axillary Lymphadenopathy
por: Healy, N. A., et al.
Publicado: (2011)

The Safety and Efficacy of Laparoscopic Surgical Staging and Debulking of Apparent Advanced Stage Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
por: Nezhat, Farr R., et al.
Publicado: (2010)

Prevalence of Tissue BRCA Gene Mutation in Ovarian, Fallopian Tube, and Primary Peritoneal Cancers: A Multi-Institutional Study
por: Lertkhachonsuk, Arb-Aroon, et al.
Publicado: (2020)

Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
por: Fu, Siqing, et al.
Publicado: (2022)

Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea
por: Kim, Se Ik, et al.
Publicado: (2022)

Peritoneal Dialysis Catheter−Fallopian Tube Fistula
por: Mandalapu, Rajendra, et al.
Publicado: (2020)

Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2020)

Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae
por: Lim, Myong Cheol, et al.
Publicado: (2018)

Prognostic factors of primary fallopian tube carcinoma
por: Akkaya, Emrah, et al.
Publicado: (2018)

Mode of primary cancer detection as an indicator of screening practice for second primary cancer in cancer survivors: a nationwide survey in Korea
por: Suh, Beomseok, et al.
Publicado: (2012)

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates
por: Liao, John B, et al.
Publicado: (2021)

Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study
por: Joung, Jae Young, et al.
Publicado: (2015)

Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea
por: Kwon, Whi-An, et al.
Publicado: (2018)

Second Primary Cancer Risk among Kidney Cancer Patients in Korea: A Population-Based Cohort Study
por: Joung, Jae Young, et al.
Publicado: (2018)

Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers
por: Braicu, E-I, et al.
Publicado: (2011)

Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer
por: Lee, Elizabeth K., et al.
Publicado: (2019)

Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy
por: Jeerakornpassawat, Dhammapoj, et al.
Publicado: (2020)

Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
por: Roque, Dana M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ja4m55275kf6pvtb50qah67dnb